Johan Eriksson Bajtner

Johan Eriksson Bajtner is a seasoned professional in the pharmaceutical industry, currently serving as the Lead Drug Substance Manager at Ferring Pharmaceuticals since April 2022. Prior experience includes pivotal roles at LEO Pharma, where responsibilities ranged from Principal Crystallization and Process Specialist to Senior Scientist in API Process Research, emphasizing project management and development of API processes for toxicology and pre-clinical studies. Johan's background also encompasses R&D roles at Magle Chemoswed AB, The Chemours Company, and DuPont Chemoswed, focusing on manufacturing campaigns and regulatory dossier compilation in compliant environments. Academic qualifications include a PhD in Organic Chemistry and a Post PhD qualification designed for aspiring Docents from Lund University, complemented by a Bachelor of Science in Law and Economics, alongside another B.Sc. in Organic Chemistry.